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Abstract
Background: Apoptosis of endothelial cells caused by reactive oxygen species plays an important role in
ischemia/reperfusion injury after cerebral infarction. Buyang Huanwu Decoction (BYHWD) has been used to treat
stroke and stroke-induced disability, however, the mechanism for this treatment remains unknown. In this study, we
investigated whether BYHWD can protect human umbilical vein endothelial cells (HUVECs) from H2O2-induced
apoptosis and explored the underlying mechanisms.
Methods: To investigate the effect of BYHWD on the apoptosis of HUVECs, we established a H2O2-induced oxidative
stress model and detected apoptosis by Hoechst 33342 and propidium iodide staining. JC-1 and DCFH-DA
assays,western blotting and electron microscopy were used to examine the mechanism of BYHWD on apoptosis.
Results: Pretreatment with BYHWD significantly inhibited H2O2-induced apoptosis and protein caspase-3 expression in
a concentration-dependent manner. In addition, BYHWD reduced reactive oxygen species production and promoted
endogenous antioxidant defenses. Furthermore, loss of mitochondrial membrane potential and structural disruption of
mitochondria were both rescued by BYHWD.
Conclusions: BYHWD protects HUVECs from H2O2-induced apoptosis by inhibiting oxidative stress damage and
mitochondrial dysfunction. These findings indicate that BYHWD is a promising treatment for cerebral ischemia diseases.
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Background
Stroke is the second leading cause of death and a major
cause of disability worldwide. About 85–90 % of strokes
are caused by ischemia (resulting from arterial occlu-
sion) [1]. Excessive production of reactive oxygen species
(ROS) such as H2O2, superoxide radicals, and hydroxyl
radicals has been observed during cerebral ischemia/
reperfusion (I/R) [2, 3]. This elevated ROS production
alters mitochondrial permeability, which reduces mito-
chondrial membrane potentials (MMP), causing the
release of Cyt-c. This activates caspase signaling path-
ways, which are important mediators of apoptosis [4–6].
Therefore, excessive ROS levels induce mitochondrial
dysfunction, which promotes ROS-mediated apoptosis
[7]. Preliminary studies have shown that ROS-induced
apoptosis of vascular endothelial cells aggravates second-
ary brain injury after cerebral infarction [8, 9]. Protecting
vascular endothelial cells against ROS-induced apoptosis
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Numerous clinical trials have demonstrated that BYHWD
improves the outcomes of ischemic stroke [10]. Recent
studies have reported neuroprotective effects of BYHWD
against cerebral I/R injury in animal experiments [11, 12].
BYHWD may also inhibit the apoptosis of nerve cells
caused by I/R injury [13]. However, the mechanism behind
the anti-apoptotic activity of BYHWD in endothelial
cells is not well defined. Our previous findings have in-
dicated that BYHWD is involved in angiogenesis by en-
hancing angiopoietin-1 expression after focal cerebral
ischemia in rats [14]. In this study, we investigated the
protective effects of BYHWD on H2O2-induced
apoptosis in human umbilical vein endothelial cells
(HUVECs) and explored the underlying mechanisms.
Methods
Composition and preparation of BYHWD
BYHWD was prepared with the following components:
Radix Astragali (Shanxi, China), Radix Angelicae Sinensis
(Gansu, China), Radix Paeoniae Rubra (Sichuan, China),
Rhizoma Ligustici Chuanxiong (Sichuan, China), Semen
Persicae (Sichuan, China), Flos Carthami (Henan, China),
and Pheretima (Guangdong, China). These components
were mixed at a ratio of 120:10:10:10:10:10:4.5 (dry
weight) [13]. All ingredients were purchased from the East
China Pharmaceutical Group Co., Ltd., Zhejiang Province,
China, and deposited at the Department of Pharmacy,
Zhejiang University after verification by Professor Dong at
the same institute. The decoction was made by boiling the
mixture in ten times the amount of distilled water at 100 °
C for 30 min. Then, the drug solution was poured out for
use and the residue boiled two more times. The total drug
solution for three times was vacuum-cooled and dried to a
powder, which was dissolved in distilled water at a final
concentration of 2.0 g/ml (equivalent to the dry weight of
the raw materials).
Qualitative and quantitative analysis of active ingredients
Based on the theories of traditional Chinese medicine, a
herbal formulation contains more than one Chinese
herb. According to the literature, the effective compo-
nents of BYHWD are astragaloside IV, paeoniflorin,
amygdalin, and tetramethylpyrazine. These active ingre-
dients were quality controlled by high-performance
liquid chromatography (HPLC) in our study [15]. Stand-
ard chemicals including astragaloside IV, paeoniflorin,
amygdalin, and tetramethylpyrazine were purchased
from the Biological Products Analysis Bureau at the
Ministry of Public Health of China. Briefly, HPLC profil-
ing was performed using an Agilent 1100 series equipped
with a quaternary solvent delivery system, auto-sampler,
and a photodiode array (PDA) detector (Waters Breeze,
USA). Separation was performed on a Cosmosil ARII
column (250 mm× 4.6 mm, 5 μm; temperature: 35 °C;
flowrate: 1 ml/min; injection volume: 10 μL). The mobile
phase used astragaloside IV, acetonitrile/water (33/67, v:v),
paeoniflorin, amygdalin, tetramethylpyrazine, and a
methanol/water (33/67, v:v) solution. The linear gradient
elution was optimized for BYHWD as follows: 2–2 % B
(0–5 min), 2–30 % B (5–50 min), 30–60 % B (50–70 min),
with a 15-min re-equilibration of the gradient elution.
Cell culture
HUVECs were obtained from ATCC (Rockville, MD,
USA) and maintained in Dulbecco’s modified Eagle’s
Medium (DMEM) (Hangzhou Sijiqing Biological Engin-
eering Materials Co., Ltd., China) supplemented with
heat-inactivated 10 % fetal bovine serum (FBS) (Hangzhou
Sijiqing Biological Engineering Materials Co., Ltd., China),
100 U/ml penicillin, and 100 U/ml streptomycin in a hu-
midified atmosphere of 5 % CO2 at 37 °C. Cells were used
at passage 4–6 in all experiments.
MTT assay
An MTT assay was used to estimate cell viability. Briefly,
HUVECs were seeded into 96-well plates (BD Falcon,
USA), at a density of 2 × 103 cells/well in DMEM supple-
mented with 10 % FBS. One day after plating, the cells
were washed and incubated in serum-free medium for
12 h. The cells were then washed again. To explore the
cytotoxicity of BYHWD on HUVECs, cells were incu-
bated with various concentrations of BYHWD (5–
45 mg/ml) for 24 h. To explore the effects of BYHWD
on H2O2-induced cytotoxicity, cells were pretreated for
6 h with culture medium containing different concentra-
tions of BYHWD (5, 15, and 30 mg/ml). The cells were
then exposed to H2O2 (320 μmol/l) diluted in culture
medium for 6 h. After H2O2 exposure, the culture super-
natant was removed and cells were washed with PBS be-
fore incubating in 150 μl MTT solution (5 mg/ml) in
culture medium at 37 °C for 3 h. After removal of the
MTT solution, the colored formazan crystals were dissolved
in 100 μl DMSO. Plates were gently shaken for 10 min be-
fore measuring the optical density at 490 nm using an
enzyme-labeled instrument (Biotek ELX 800/FLX800).
Hoechst 33342 and propidium iodide (PI) staining
Apoptotic HUVECs were identified by Hoechst 33342
and PI (Hangzhou Baoke Biological Technology Co.,
Ltd., China) staining. Briefly, HUVECs were seeded in a
6-well plate (BD Falcon, USA) at a density of 1 × 104
cells/well in DMEM supplemented with 10 % FBS. One
day after plating, the cells were washed and incubated in
serum-free medium for 12 h. The cells were then
washed again and pretreated for 6 h with different con-
centrations of BYHWD (5, 15, and 30 mg/ml). The cells
were then exposed to H2O2 (320 μmol/l) for 6 h before
double-staining with Hoechst 33342 and then PI for
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10 min each at 37 °C according to the manufacturer’s in-
structions. Cells were observed under a fluorescence
microscope (Olympus, Japan). Hoechst 33342 was ex-
cited at 361 nm and emitted blue fluorescence at
460 nm. PI was excited at 480 nm and red fluorescence
was detected at 610 nm. Data were analyzed using Image
Pro plus software (Media Cybernetics). Data were
expressed as the percentage of apoptotic cells.
Western blotting
After incubating as described above, cells were seeded
into 6-well plates. Cells were lysed in 200 μl RIPA lysis
buffer (Hangzhou Baoke Biological Engineering Mate-
rials Co., Ltd., China), centrifuged at 20,000 g for 5 min
at 4 °C, and the supernatant was collected. Nuclear ex-
tracts were collected according to the protocol of the
nuclear extraction kit (Hangzhou Baoke Biological En-
gineering Materials Co., Ltd., China). Protein extracts
were quantified using a BCA protein assay kit
(Hangzhou Baoke Biological Engineering Materials Co.,
Ltd., China). Equal amounts of proteins (50 μg per lane)
were separated on a 10 % SDS-polyacrylamide gel by
electrophoresis and transferred onto a polyvinylidene
difluoride membrane (Millipore, Milford, MA, USA).
Membranes were blocked with 5 % fat-free milk at room
temperature for 2 h and incubated with primary anti-
bodies against active caspase-3 (Abcam, USA, 1:1000) or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(Santa Cruz, CA, USA, 1:1000) at 4 °C overnight. After
primary antibody incubation, membranes were washed
three times in TBST then incubated in secondary antibody
solutions for 2 h at room temperature. After washing, the
signals were visualized using enhanced chemilumines-
cence and X-ray film (Kodak, USA). Protein levels were
quantified by densitometry. Data were expressed as the
ratio of active caspase-3 to GAPDH.
Measurement of intracellular ROS
Measurement of intracellular ROS was based on ROS-
mediated conversion of non-fluorescent 2,7-DCFH-DA
into fluorescent DCFH. Briefly, HUVECs were seeded
into a 6-well plate (BD Falcon, USA) at a density of 1 ×
104 cells/well in DMEM supplemented with 10 % FBS.
One day after plating, the cells were washed and incu-
bated in serum-free medium for 12 h. The cells were
washed and pretreated with BYHWD (30 mg/ml) for
6 h. The cells were then exposed to H2O2 (320 μmol/l)
for 6 h before incubating in 2,7-DCFH-DA (Sigma, USA,
5 μM) in PBS for 30 min. Cells were washed three times
with PBS then the DCFH fluorescence from each well
was excited at 485 nm and the emission was measured
at 520 nm by fluorescence microscopy (Olympus, Japan).
For spectrofluorophotometry analysis, the cells were col-
lected and analyzed. The fluorescence of DCFH was
detected using a spectrofluorophotometer (Amersham
Biosciences, USA). Data were expressed relative to the
mean sham value.
Measurement of superoxide dismutase (SOD) and
malondialdehyde (MDA) levels
The levels of SOD and MDA were determined using
commercially available kits (Nanjing Jiancheng Biological
Engineering Materials Co., Ltd., China). Briefly, after in-
cubating as described above, cells were lysed and centri-
fuged at 12,000 g for 10 min at 4 °C, to collect the
supernatant. The SOD and MDA levels in the super-
natant were measured according to the kit protocol and
analyzed on a spectrophotometer,The absorbance was
read at 550 nm (SOD) and 450 nm (MDA). The levels
were calculated using a standard calibration curve and
expressed in U/mg (SOD) and nmol/ml (MDA). Data
were expressed as relative to the mean sham value.
Transmission electron microscopy
Electron microscopy was performed to examine the
morphology of the mitochondria in HUVECs. Briefly, after
incubating as described above, cells were collected and
prefixed with 2.5 % w/v glutaraldehyde for 2 h, rinsed
three times in 0.1 mol/l PBS (pH 7.4), and post-fixed for
2 h in 1 % w/v osmium tetroxide at −4 °C. The fixed cells
were dehydrated through an ethanol series then com-
pletely dehydrated in absolute ethanol. Cells were de-
tached using propylene oxide and infiltrated with Spurr
low-viscosity embedding medium (Wuhan Boshide
Biological Technology Co., Wuhan, China). Sections were
cut using an ultramicrotome with a diamond knife, and
stained with uranyl acetate and lead citrate. Cells were
observed using a transmission electron microscope (JEM-
1230, Olympus Corporation, Tokyo, Japan).
Measurement of MMP
MPP was assessed using the lipophilic cationic probe
JC-1, which is a sensitive fluorescent dye (Invitrogen,
USA). Briefly, after incubating as described above, cells
were incubated with 5 mM JC-1 dye (Molecular Probes)
at 37 °C for 15 min. Cells were then washed three times
with PBS and immediately analyzed with a fluorescence
microscope (Olympus, Japan). Red emission indicated
membrane potential-dependent JC-1 aggregates in the
mitochondria. Green fluorescence indicated the mono-
meric form of JC-1 entering the cytoplasm after mito-
chondrial membrane depolarization. The ratio of red to
green fluorescence intensity was measured and data
were expressed as relative to the mean sham value.
Statistical analysis
All data were expressed as the mean ± standard devi-
ation (SD). Statistical analysis was performed using the
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Student’s t-test and ANOVA. Significance was accepted
at P<0.05. SPSS 19.0 software was used for statistical
analysis.
Results
Qualitative and quantitative analysis of BYHWD
components
To identify BYHWD extracts containing active ingredi-
ents, quality control was performed by HPLC. BYHWD
contained astragaloside IV, paeoniflorin, and amygdalin,
but not tetramethylpyrazine (Fig. 1). The summit reten-
tion time of astragaloside IV, paeoniflorin, and amyg-
dalin was approximately 35 min, 11.5 min, and 6 min,
respectively. The content of astragaloside IV, paeoni-
florin, and amygdalin was 0.58, 1.63, and 1.82 mg/g,
respectively.
Cytoactivity and cytotoxicity of BYHWD in HUVECs
To determine the optimal experimental concentration of
BYHWD, we measured the viability of HUVECs after
treatment with various concentrations of BYHWD by
MTT assay. Cytoactivity was not significantly increased
by BYHWD at concentrations of 5–30 mg/ml, but cyto-
toxicity increased in a dose-dependent manner at con-
centrations of 35–45 mg/ml (Fig. 2). To investigate
whether effects of BYHWD were dose-dependent, we se-
lected low (5 mg/ml), medium (15 mg/ml) and high
(30 mg/ml) doses for experiments.
BYHWD inhibits H2O2-induced cytotoxicity in HUVECs
To evaluate the effect of BYHWD on H2O2-induced
cytotoxicity in HUVECs, we measured the viability of
BYHWD-treated HUVECs by MTT assay. BYHWD sig-
nificantly increased cell viability in a dose-dependent
manner after H2O2-induced cytotoxicity (Fig. 3). These
results suggest that BYHWD protects HUVECs from
H2O2-induced injury.
BYHWD inhibits H2O2-induced apoptosis in HUVECs
To evaluate the effect of BYHWD on H2O2-induced
apoptosis, cells were stained with Hoechst 33342 and PI.
Cell nuclei condensed into a bright blue was defined as
strongly expressing Hoechst 33342, nornal nuclei with
common blue defined as expressing Hoechst 33342. The
changes in cell nuclei of apoptotic cells were defined by
Hoechst 33342 staining as described previously [16].
Cells expressing Hoechst 33342 and not expressing PI
were considered unstressed. Cells strongly expressing
Hoechst 33342 and not expressing PI were considered
early apoptotic cells. Cells strongly expressing Hoechst
33342 and expressing PI were classified as late apoptotic
cells. Cells expressing Hoechst 33342 and strongly ex-
pressing PI were considered dead. Exposure to H2O2 in-
creased apoptosis (Fig. 4) and treatment with BYHWD
significantly reduced apoptosis in a dose-dependent
manner (Fig. 4). This suggests that BYHWD may block
an apoptotic pathway.
BYHWD decreases H2O2-induced caspase-3 expression
H2O2-induced caspase-3 cleavage is known to regulate cell
apoptosis [6]. To determine whether BYHWD affects this
process, we measured caspase-3 expression by western
blot. Exposure to H2O2 significantly increased caspase-3
expression (Fig. 5) and BYHWD treatment significantly
reduced caspase-3 expression in a dose-dependent man-
ner. These results further verify that BYHWD inhibits
H2O2-induced apoptosis.
BYHWD inhibits H2O2-induced ROS production
Exogenous addition of H2O2 induces intracellular ROS
production, which affects cell metabolism [17]. To inves-
tigate whether inhibition of apoptosis by BYHWD is
related to the intracellular production of ROS, we mea-
sured intracellular ROS levels using fluorescence micros-
copy and spectrofluorophotometry with DCFH-DA.
DCFH-DA is cleaved intracellularly by esterases and
subsequently oxidized to DCFH by ROS. Green fluores-
cence produced by DCFH indicates abnormally high
ROS levels. Exposure to H2O2 (320 μmol/l) induced a
burst of green fluorescence in HUVECs (Fig. 6), which
was inhibited by BYHWD. These findings suggest that
BYHWD inhibits H2O2-induced ROS production.
BYHWD decreased MDA levels and increased SOD levels
induced by H2O2
MDA levels reflect the degree of lipid peroxidation by
ROS-induced cell damage and SOD activity indirectly
reflects the ability to eliminate ROS [18]. To determine
whether BYHWD affects ROS-induced cell damage, we
examined intracellular MDA and SOD levels. Exposure
to H2O2 reduced MDA and increased SOD levels and
treatment with BYHWD reduced MDA and further in-
creased SOD levels (Fig. 7).
BYHWD inhibits H2O2-induced ultrastructural disruption
of mitochondria
Mitochondria are important organelles for cellular en-
ergy production and are involved in cell apoptosis [19].
To demonstrate whether inhibition of apoptosis by
BYHWD is related to changes in mitochondria ultra-
structure, we examined HUVECs by transmission elec-
tron microscopy. H2O2 caused mitochondrial swelling,
disrupted the mitochondrial membrane, and fragmented
the mitochondrial cristae in HUVECs (Fig. 8). Mito-
chondrial disruption by H2O2 was rescued in HUVECs
by BYHWD treatment (30 mg/ml). Therefore, BYHWD
inhibits H2O2-induced ultrastructural disruption of
HUVEC mitochondria.
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BYHWD restores H2O2-induced reduction of MMP
Opening of mitochondrial permeability transition pores by
ROS causes mitochondrial dysfunction because of mito-
chondrial matrix swelling and outer membrane rupture
[20]. To examine this, we measured MMP in HUVECs
using JC-1. High MMP is indicated by the production of red
fluorescence and depolarized regions are indicated by green
fluorescence. Exposure to H2O2 reduced the production red
Fig. 1 Representative HPLC chromatograms of active BYHWD components and standard controls. BYHWD contains astragaloside IV, paeoniflorin,
and amygdalin, but not tetramethylpyrazine. Summit retention times of astragaloside IV, paeoniflorin, and amygdalin were 35 min, 11.5 min and
6 min, respectively
Shen et al. BMC Complementary and Alternative Medicine  (2016) 16:154 Page 5 of 11
fluorescence and increased the intensity of green fluores-
cence (Fig. 9). BYHWD treatment increased the production
of red fluorescence and reduced the production of green
fluorescence, demonstrating that BYHWD can restore
H2O2-induced loss of MPP.
Discussion
Vascular endothelial cells maintain vascular permeability
and vascular responses to a variety of physiological and
pathological stimuli [21]. When the structure and func-
tion of vascular endothelial cells are impaired, lesions
form in the lumen (e.g. thrombosis, atherosclerosis and
vasculitis), causing vascular stenosis or occlusion [20]. If
this occurs in cerebral vessels, it can cause ischemic
cerebrovascular disease, such as transient ischemic at-
tack and cerebral infarction [22]. Endothelial cell prolif-
eration and angiogenesis are important for neurological
recovery after cerebral infarction [23]. However, exces-
sive ROS production aggravates endothelial cell injury
during cerebral I/R [24, 25]; endothelial cells produce
many ROS, which reduces antioxidant activity and sensi-
tivity to exogenous ROS [26]. Neurons also produce
ROS, which increases the damage done to endothelial
cells by oxygen-free radicals [27]. Preliminary studies
have shown that ROS-induced oxidative stress induces
lipid peroxidation and protein damage in membranes,
alters the antioxidant system, mutates DNA, alters gene
expression, and induces vascular endothelial cell apop-
tosis, thereby aggravating brain ischemia and hypoxia
[28]. Protecting vascular endothelial cells from ROS-
induced apoptosis may help the treatment of cerebrovas-
cular diseases. HUVECs are the most commonly used
model in cardio-cerebrovascular disease research [20, 29].
For this reason, we selected H2O2-induced apoptosis in
HUVECs as an in vitro model of endothelial cell oxidative
stress damage after cerebral ischemia.
BYHWD is one of the most classical medicinal pre-
scriptions, comprised of seven active ingredients: Radix
Astragali, Radix Angelicae Sinensis, Radix Paeoniae
Rubra, Rhizoma Ligustici Chuanxiong, Semen Persicae,
Flos Carthami, and Pheretima [13]. Based on the theor-
ies of traditional Chinese medicine, the combined effects
of multiple herbs within a formula may have a power-
fully curative effect. A traditional herbal formulation
such as BYHWD is prescribed according to the princi-
ples of monarch, minister, assistant and guide. The mon-
arch Radix Astragali is the chief drug for treating the
disease, the minister Radix Angelicae Sinensis intensifies
the effect of the monarch drug, the assistants Radix
Paeoniae Rubra, Rhizoma Chuanxiong, Semen Persicae,
and Flos Carthami treat the secondary symptoms or in-
hibit the toxicity of the monarch drug, and the guide
drug Pheretima guides the herbs to the diseased regions
and balances the effects of all herbs. Chemical investiga-
tions have revealed that the active constituents of
BYHWD are numerous and diverse. Radix Astragali con-
tains flavonoids (formononetin, ononin, calycosin and its
glycoside), saponins (astragaloside I, II, III, IV, V, VI, VII,
VIII), polysaccharides and amino acid; Radix Angelicae
Sinensis contains ferulic acid; Radix Paeoniae Rubra con-
tains paeoniflorin, oxypaeoniflorin, benzoylpaeoniflorin
and ligustilide; Rhizoma Ligustici Chuanxiong contains
tetramethylpyrazine, perlolyrine, ligustilide, ferulic acid,
and protocatechuic acid; Semen Persicae contains amyg-
dalin, prunasin, sterol, and organic acid; Flos Carthami
contains hydroxysafflor yellow A; and Pheretima contains
hypoxanthine [15, 30]. Pharmacological studies also have
Fig. 3 Protective effects of BYHWD on H2O2-induced viability loss in
HUVECs. Quantitative analysis of the effect of BYHWD on H2O2-induced
viability loss in HUVECs. Values are shown as means± SD (n=6).**P<0.01,
compared to sham group. ##P<0.01, compared to H2O2 group (320 μmol/l)
Fig. 2 Cytoactivity and cytotoxicity of HUVECs treated with various
concentrations of BYHWD. HUVEC viability after treatment with
different concentrations of BYHWD (5–45 mg/ml) for 24 h. Values are
shown as means ± SD (n = 6).**P < 0.01, compared to sham group
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revealed that the active components of BYHWD contains
calycosin-O-β-D-glucoside, formononetin, ononin, calyco-
sin, astragaloside IV and astragaloside I from Radix
Astragali, paeoniflorin from Radix Paeoniae Rubra, tetra-
methylpyrazine, ferulic acid and ligustilide from Radix
Angelicae Sinensis and Rhizoma Ligustici Chuanxiong,
amygdalin from Semen Persicae, hydroxysafflor yellow A
and kaempferol from Flos Carthami [30–32].
BYHWD has been used to treat stroke and stroke-
induced disability in China for centuries [33]. Recent
studies have reported that BYHWD has a protective effect
on nerve cells in humans and animal models [12, 34].
BYHWD exerts its neuroprotective effects by promoting
the growth and differentiation of nerve cells [20, 35], and
inhibiting neural apoptosis and inflammation after cere-
bral infarction [36]. However, the protective mechanisms
of BYHWD in endothelial cells after brain ischemia are
currently undefined. To address this, we explored the
protective effects and mechanisms of BYHWD on H2O2-
induced apoptosis in HUVECs.
H2O2 exposure induced apoptosis, cytoactivity, ROS in-
crease, and mitochondrial disorder in HUVECs. BYHWD
inhibited H2O2-induced apoptosis in HUVECs by reducing
intracellular levels of ROS and MDA. In addition, BYHWD
increased intracellular SOD levels and restored the MMP
and ultrastructural integrity of mitochondria. We have dem-
onstrated for the first time that BYHWD protects against
H2O2-induced apoptosis in HUVECs by inhibiting a
ROS-mediated mitochondrial dysfunction pathway.
These findings may help to identify novel drug targets
and therapies for cerebrovascular diseases.
Apoptosis is a process of programmed cell death in
which defective and harmful cells are eliminated to
maintain homeostasis [37]. There are three pathways in-
volved in apoptosis: the mitochondrial pathway, death
receptor pathway, and endoplasmic reticulum stress
Fig. 4 Effects of BYHWD on H2O2-induced apoptosis in HUVECs. a Apoptotic cells were observed using a fluorescence microscope by Hoechst
33342 and PI staining in HUVECs. b Quantitative data showed the percentage of apoptotic cells according to treatment in HUVECs. Values are
shown as means ± SD (n = 10). **P < 0.01, compared to sham group. ##P < 0.01, compared to H2O2 group (320 μmol/l)
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Fig. 6 Effects of BYHWD on H2O2-induced intracellular ROS levels in HUVECs. a Representative images of intracellular ROS in HUVECs by
fluorescence microscopy.b Quantitative analysis of intracellular ROS in HUVECs by spectrofluorophotometry. Values are shown as means ± SD
(n = 10). **P < 0.01, compared to sham group. ##P < 0.01, compared to H2O2 group (320 μmol/l)
Fig. 5 Effects of BYHWD on H2O2-induced caspase-3 expression in HUVECs. a Caspase-3 protein expression in HUVECs were examined by western
blotting. b Quantitative analysis of band densities for caspase-3 expression in HUVECs were measured. Values are shown as means ± SD (n = 3).
**P < 0.01, compared to sham group. ##P < 0.01, compared to H2O2 group (320 μmol/l)
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pathway [38]. Mitochondria are key regulators of cellular
energy homeostasis and play a central role in apoptosis
[39]. Mitochondrial apoptotic signals decrease the MMP,
causing Cyt-c and Smac and other contents to leak from
the mitochondria [4, 5]. Smac speeds up apoptosis and
Cyt-c promotes apoptosis by activating caspase-3 [4, 6].
We have shown that H2O2 causes mitochondrial swell-
ing, disruption of mitochondrial cristae, reduced MMP
and activation of caspase-3 in HUVECs, eventually lead-
ing to apoptosis. BYHWD treatment reversed these ef-
fects and attenuated H2O2-induced apoptosis through
the mitochondrial pathway.
ROS are powerful oxidizing agents in cells and
established regulators of apoptosis [40]. Oxidative
stress and mitochondrial function are positively corre-
lated. Oxidative stress can cause cellular apoptosis by
mitochondria-dependent pathways [41]. H2O2 can
cause endothelial cell injury by inducing mitochon-
drial dysfunction, including loss of MMP and the
MMP transition, which increases the formation of
ROS by inhibiting the respiratory chain [20, 29]. Ex-
cessive ROS cause peroxidation of polyunsaturated
fatty acids and lipids, damaging membrane fluidity,
permeability and integrity. MDA levels reflect the de-
gree of lipid peroxidation and indirectly the degree of
cell damage. SOD is a free-radical scavenger and SOD
levels indirectly reflect the level of ROS elimination
[18]. We observed that intracellular ROS and MDA
levels increased and SOD levels decreased in
HUVECs exposed to H2O2. BYHWD reduced ROS
production in HUVECs, which increased the activity
of SOD and reduced MDA levels, indicating that
BYHWD has antioxidant effects. We propose that
Fig. 8 BYHWD inhibits H2O2-induced ultrastructural disruption of mitochondria in HUVECs. Transmission electron micrographs showed swelling
mitochondria, disrupted the mitochondrial membrane, and fragmented the mitochondrial cristae induced by H2O2 (320 μmol/l) (a and b).
Mitochondrial disruption was rescued by BYHWD treatment (30 mg/ml) (c)
Fig. 7 Effects of BYHWD on H2O2-induced MDA and SOD levels in
HUVECs. a Quantitative analysis of intracellular MDA levels in HUVECs.
b Quantitative analysis of intracellular SOD levels in HUVECs. Values are
shown as means ± SD (n = 10). **P < 0.01, compared to sham group.
##P < 0.01, compared to H2O2 group (320 μmol/l)
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these effects represent the mechanism by which BYHWD
inhibits H2O2-mediated apoptosis in HUVECs.
Conclusion
We have shown that BYHWD significantly attenuates
H2O2-induced apoptosis in HUVECs. Furthermore,
BYHWD inhibited intracellular ROS production, in-
creased SOD activity, reduced MDA levels, reversed
MMP decline and rescued structural disruption of mito-
chondria. These findings suggest that the anti-apoptotic
mechanisms of BYHWD involve inhibiting ROS-mediated
mitochondrial dysfunction pathways in HUVECs.
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Fig. 9 BYHWD restores H2O2-induced reduction of MMP in HUVECs. a Representative images of MMP in HUVECs measured by JC-1. b Quantitative analysis
of MMP in HUVECs. Values are shown as means ± SD (n= 9). **P< 0.01, compared to sham group. ##P< 0.01, compared to H2O2 group (320 μmol/l)
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